GILD vs TWLO · P/E 18, rev $7.80B vs P/E 1087, rev $2.91B
Gilead Sciences Inc (GILD) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the GILD and TWLO stock pages for the full models.
Not investment advice.